Summary
The report provides the latest information on 17 vaccine candidates under clinical development and summarizes ongoing, planned, and recently completed clinical trials in two comprehensive tables. Narrative updates profile some of the candidates that generated the most news over the past year, because they either reported clinical trial results (H56:IC31, BCG revaccination), began major new efficacy trials (M72/AS01E, MTBVAC), prepared to open anticipated studies (QTP101 / ID93/GLA-SE), or kept everyone waiting for more information (VPM1002, MIP).
Geographies
United States of America 